Nanoparticulate systems for polynucleotide delivery

International Journal of Nanomedicine

Volumn 2, Issue 3, 2007, Pages 353-360

  Basarkar, Ashwin ^a   Singh, Jagdish ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Gene delivery; Gene therapy; Polymers liposomes; Polynucleotides; Transfectiom efficiency

Indexed keywords

CHITOSAN; DNA; GOLD; LIPOPLEX; LIPOSOME; NANOCARRIER; NANOPARTICLE; NANOSPHERE; NANOTUBE; POLYETHYLENEIMINE; POLYGLACTIN; POLYLACTIC ACID; POLYLYSINE; POLYMER; POLYMETHACRYLIC ACID; POLYNUCLEOTIDE; SMALL INTERFERING RNA;

DRUG FORMULATION; GENETIC TRANSFECTION; HUMAN; INTERNALIZATION; NANOPHARMACEUTICS; NANOTECHNOLOGY; NANOTOXICOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PLASMA CLEARANCE; REVIEW; STEREOSPECIFICITY;

CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; GENE TARGETING; GENE THERAPY; NANOMEDICINE; NANOSTRUCTURES; POLYNUCLEOTIDES; TRANSFECTION;

EID: 69749099777     PISSN: 11769114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Akinc A, Langer R. 2002. Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking. Biotechnol Bioeng, 78(5):503-8.
2. Akinc A, Anderson DG, Lynn DM, et al. 2003. Synthesis of poly (beta-amino ester)s optimized for highly effective gene delivery. Bioconjug Chem, 14:979-88.
3. Behr JP. 1997. The Proton Sponge -A Trick to Enter Cells the Viruses Did Not Exploit. CHIMIA, 51:34-6.
4. Bianco A. 2004. Carbon nanotubes for the delivery of therapeutic molecules. Expert Opin Drug Deliv, 1:57-65.
5. Bozkir A, Saka OM. 2004a. Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics. Drug Deliv, 11:107-12.
6. Bozkir A, Saka OM. 2004b. Chitosan-DNA nanoparticles: effect on DNA integrity, bacterial transformation and transfection efficiency. J Drug Target, 12:281-8.
7. Cheng J, Teply BA, Sherifi I, et al. 2007. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials, 28:869-76. Choi HS, Ooya T, Yui N. 2006. One-pot synthesis of a polyrotaxane via selective threading of a PEI-b-PEG-b-PEI copolymer. Macromol Biosci, 6:420-4.
8. Chollet P, Favrot MC, Hurbin A, et al. 2002. Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J Gene Med, 4:84-91.
9. Cohen H, Levy RJ, Gao J, et al. 2000. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther, 7:1896-905.
10. Dass CR, Burton MA. 2003. Modified microplex vector enhances transfection of cells in culture while maintaining tumour-selective gene delivery in-vivo. J Pharm Pharmacol, 55:19-25.
11. Davis SS. 1997. Biomedical applications of nanotechnology - implications for drug targeting and gene therapy. Trends Biotechnol, 15:217-24.
12. De Laporte L, Cruz Rea J, Shea LD. 2006. Design of modular non-viral gene therapy vectors. Biomaterials, 27:947-54.
13. Delie F, Berton M, Allemann E, et al. 2001. Comparison of two methods of encapsulation of an oligonucleotide into poly(D, L-lactic acid) particles. Int J Pharm, 214:25-30.
14. Desai MP, Labhasetwar V, Amidon GL, et al. 1996. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res, 13:1838-45.
15. Desai MP, Labhasetwar V, Walter E, Levy RJ, et al. 1997. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res, 14:1568-73.
16. De Smedt SC, Demeester J, Hennink WE. 2000. Cationic polymer based gene delivery systems. Pharm Res, 17:113-26.
17. Dubruel P, Christiaens B, Vanloo B, et al. 2003. Physicochemical and biological evaluation of cationic polymethacrylates as vectors for gene delivery. Eur J Pharm Sci, 18:211-20.
18. Dubruel P, Christiaens B, Rosseneu M, et al. 2004. Buffering properties of cationic polymethacrylates are not the only key to successful gene delivery. Biomacromolecules, 5:379-88.
19. Felgner PL, Gadek TR, Holm M, et al. 1987. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA, 84:7413-17.
20. Feng M, Lee D, Li P. 2006. Intracellular uptake and release of poly(ethyleneimine)-co-poly(methyl methacrylate) nanoparticle/pDNA complexes for gene delivery. Int J Pharm, 311:209-14.
21. Ferrari F, Rossi S, Bonferoni MC, et al. 1997. Characterization of rheological and mucoadhesive properties of three grades of chitosan hydrochloride. Farmaco, 52:493-7.
22. Gebhart CL, Kabanov AV. 2001. Evaluation of polyplexes as gene transfer agents. J Control Release, 73:401-16.
23. Gersting SW, Schillinger U, Lausier J, et al. 2004. Gene delivery to respiratory epithelial cells by magnetofection. J Gene Med, 6:913-22.
24. Hafez IM, Maurer N, Cullis PR. 2001. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther, 8:1188-96.
25. Heidel J, Mishra S, Davis ME. 2005. Molecular conjugates. Adv Biochem Eng Biotechnol, 99:7-39.
26. Hickman MA, Malone RW, Lehmann-Bruinsma K, et al. 1994. Gene expression following direct injection of DNA into liver. Hum Gene Ther, 5:1477-83.
27. Howard KA, Rahbek UL, Liu X, Damgaard CK, et al. 2006. RNA Interference in Vitro and in Vivo Using a Novel Chitosan/siRNA Nanoparticle System. Mol Ther, 14:476-84.
28. Hu FQ, Zhao MD, Yuan H, et al. 2006. A novel chitosan oligosaccharidestearic acid micelles for gene delivery: properties and in vitro transfection studies. Int J Pharm, 315:158-66.
29. Huth S, Lausier J, Gersting SW, et al. 2004. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med, 6:923-36.
30. Katas H, Alpar HO. 2006. Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release, 2006 Jul 25.
31. Katayose S, Kataoka K. 1998. Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol)-poly(L-lysine) block copolymer. J Pharm Sci, 87:160-3.
32. Kawano T, Yamagata M, Takahashi H, et al. 2006. Stabilizing of plasmid DNA in vivo by PEG-modified cationic gold nanoparticles and the gene expression assisted with electrical pulses. J Control Release, 111:382-9.
33. Kim IS, Lee SK, Park YM, et al. 2005. Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier. Int J Pharm, 298:255-62.
34. Kim DH, Martin DC. 2006. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials, 27:3031-7.
35. Kommareddy S, Tiwari SB, Armiji MM. 2005. Long-circulating polymeric nanovectors for tumor-selective gene delivery. Technol Cancer Res Treat, 4:615-25.
36. Koping-Hoggard M, Tubulekas I, Guan H, et al. 2001. Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther, 8:1108-21.
37. Koping-Hoggard M, Varum KM, Issa M, et al. 2004. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther, 11:1441-52.
38. Kreuter J, Alyautdin RN, Kharkevich DA, et al. 1995. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res, 674:171-4.
39. Kursa M, Walker GF, Roessler V, et al. 2003. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjug Chem, 14:222-31.
40. Kwoh DY, Coffin CC, Lollo CP, et al. 1999. Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver. Biochim Biophys Acta, 1444:171-90.
41. Lappalainen K, Jaaskelainen I, Syrjanen K, et al. 1994. Comparison of cell proliferation and toxicity assays using two cationic liposomes. Pharm Res, 11:1127-31.
42. Lavertu M, Methot S, Tran-Khanh N, et al. 2006. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials, 27:4815-24.
43. Lee H, Jeong JH, Park TG. 2002. PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. J Control Release, 79:283-91.
44. Lemieux P, Vinogradov SV, Gebhart CL, et al. 2000. Block and graft copolymers and NanoGel copolymer networks for DNA delivery into cell. J Drug Target, 8:91-105.
45. Li P, Zhu JM, Sunintaboon P, et al. 2002. New route to amphiphilic coreshell polymer nanospheres: graft copolymerization of methyl methacrylate from water-soluble polymer chains containing amino groups. Langmuir, 18: 8641-6.
46. Little SR, Lynn DM, Ge Q, et al. 2004. Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc Natl Acad Sci U S A, 101:9534-9.
47. Little SR, Lynn DM, Puram SV, et al. 2005. Formulation and characterization of poly (beta amino ester) microparticles for genetic vaccine delivery. J Control Release, 107:449-62.
48. Liu F, Huang L. 2002. Development of non-viral vectors for systemic gene delivery. J Control Release, 78:259-66.
49. Lynn D and Langer R. 2000. Degradable Poly(β-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA. J Am Chem Soc, 122:10761-8.
50. Merdan T, Kunath K, Fischer D, et al. 2002. Intracellular processing of poly(ethylene imine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments. Pharm Res, 19:140-6.
51. Moghimi SM, Symonds P, Murray JC, et al. 2005. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/ therapy. Mol Ther, 11:990-5.
52. Moriguchi R, Kogure K, Akita H, et al. 2005. A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids. Int J Pharm. 301:277-85.
53. Murakami H, Nakashima N. 2006. Soluble carbon nanotubes and their applications. J Nanosci Nanotechnol, 6:16-27.
54. Panyam J, Zhou WZ, Prabha S, et al. 2002. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J, 16: 1217-26.
55. Park MR, Han KO, Han IK, et al. 2005. Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers. J Control Release, 105:367-80.
56. Ravi Kumar M, Hellermann G, Lockey RF, et al. 2004. Nanoparticle-mediated gene delivery: state of the art. Expert Opin Biol Ther, 4:1213-24.
57. Ribeiro S, Hussain N, Florence AT. 2005. Release of DNA from dendriplexes encapsulated in PLGA nanoparticles. Int J Pharm, 298:354-60.
58. Robbins PD, Ghivizzani SC. 1998. Viral vectors for gene therapy. Pharmacol Ther, 80:35-47.
59. Rosca ID, Watari F, Uo M. 2004. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J Control Release, 99:271-80.
60. Ruponen M, Honkakoski P, Ronkko S, et al. 2003. Extracellular and intracellular barriers in non-viral gene delivery. J Control Release, 93:213-17.
61. Sandhu KK, McIntosh CM, Simard JM, et al. 2002. Gold nanoparticle-mediated transfection of mammalian cells. Bioconjug Chem, 13:3-6. Sato T, Ishii T, Okahata Y. 2001. In vitro gene delivery mediated by chitosan. effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials, 22:2075-80.
62. Scherer F, Anton M, Schillinger U, et al. 2002. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther, 9:102-9.
63. Shenoy D, Fu W, Li J, et al. 2006. Surface functionalization of gold nanoparticles using hetero-bifunctional Poly (ethylene glycol) spacer for intracellular tracking and delivery. Int J Nanomedicine, 1:51-8.
64. Shive MS, Anderson JM. 1997. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 28:5-24.
65. Stewart MJ, Plautz GE, Del Buono L, et al. 1992. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum Gene Ther, 3:267-75.
66. Talsma SS, Babensee JE, Murthy N, et al. 2006. Development and in vitro validation of a targeted delivery vehicle for DNA vaccines. J Control Release, 112:271-9.
67. Thomas M, Ge Q, Lu JJ, et al. 2005. Cross-linked small polyethylenimines: while still nontoxic, deliver DNA efficiently to mammalian cells in vitro and in vivo. Pharm Res, 22:373-80.
68. Torchilin VP. 2006. Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng, 8:343-75.
69. Tousignant JD, Gates AL, Ingram LA, et al. 2000. Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice. Hum Gene Ther, 11:2493-513.
70. Vinogradov SV, Bronich TK, Kabanov AV. 2002. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Deliv Rev, 54:135-47.
71. Vogt A, Combadiere B, Hadam S, et al. 2006.40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol, 126:1316-22.
72. Wagner E, Plank C, Zatloukal K, et al. 1992. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA, 89:7934-8.
73. Walther W, Stein U. 2000. Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs, 60:249-71.
74. Wiethoff CM, Middaugh CR. 2003. Barriers to nonviral gene delivery. J Pharm Sci, 92:203-17.
75. Wolff JA, Malone RW, Williams P, et al. 1990. Direct gene transfer into mouse muscle in vivo. Science, 247:1465-8.
76. Xenariou S, Griesenbach U, Ferrari S, et al. 2006. Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo. Gene Ther, 2006 Jun 1; [Epub ahead of print]
77. Yuan X, Li L, Rathinavelu A, et al. 2006. SiRNA drug delivery by biodegradable polymeric nanoparticles. J Nanosci Nanotechnol. 6:2821-8.
78. Yun YH, Jiang H, Chan R, et al. 2005. Sustained release of PEG-g-chitosan complexed DNA from poly(lactide-co-glycolide). J Biomater Sci Polym Ed, 16:1359-78.
79. Zhang S, Xu Y, Wang B, et al. 2004. Cationic compounds used in lipoplexes and polyplexes for gene delivery. J Control Release, 100:165-80.
80. Zhong Z, Feijen J, Lok MC, et al. 2005. Low molecular weight linear polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine triblock copolymers: synthesis, characterization, and in vitro gene transfer properties. Biomacromolecules, 6:3440-8.